Former Administrator of the U.S. Small Business Administration Hector Barreto Joins Pathway Genomics’ Strategic Advisory Board
Posted on 08/17/2015 in Press Releases
San Diego, CA – August 18, 2015 –Pathway Genomics, a global precision medical diagnostics company with mobile health applications designed to empower physicians and their patients to take control of their health and wellness, has announced today that Hector Barreto, the 21st Administrator of the U.S. Small Business Administration, has joined the Company’s Strategic Advisory Board.
Mr. Barreto was nominated to the U.S. Small Business Administration by former President George W. Bush and served as Administrator for five years. He is a nationally recognized public speaker, and a leader and commentator on key issues concerning business, politics, and the Latino community.
“Throughout his career, Hector Barreto has demonstrated an impressive ability to provide national leadership in both the Latino and business communities,” said Jim Plante, Pathway Genomics’ Founder and CEO. “He shares our vision for closing the healthcare disparity gap in the Latino population through preventative care such as our BRCATrue™– Hispanic (8-site) cancer test which is specifically targeted to pathogenic variants found in Mexican-Americans and possibly other Latino populations.”
“Pathway Genomics is leading the way in preventative healthcare,” said Barreto. “I am excited to work with a company that is dedicated to helping people understand their potential disease risk and providing them with invaluable genetic information to improve their health.”
Currently, Mr. Barreto is Chairman of The Latino Coalition (TLC) as well as a member of the board on the United States Chamber of Commerce and Minority Business Hall of Fame.
About Pathway Genomics Corporation
Since its founding in 2008, Pathway Genomics has rapidly become a leader in the commercial healthcare industry. Pathway Genomics’ success lies in its commitment to deliver innovative healthcare solutions. The company’s program with IBM Watson is the first of its kind. The program is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.
Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit https://www.pathway.com or follow us on Twitter, LinkedIn and Facebook.